1,2, 4-Triazine-3,5 (2H,4H)-dione, 2-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-
Modify Date: 2024-01-23 17:42:20
1,2, 4-Triazine-3,5 (2H,4H)-dione, 2-(2-deoxy-.beta.-D-erythro-pentofuranosyl)- structure
|
Common Name | 1,2, 4-Triazine-3,5 (2H,4H)-dione, 2-(2-deoxy-.beta.-D-erythro-pentofuranosyl)- | ||
|---|---|---|---|---|
| CAS Number | 20500-29-2 | Molecular Weight | 229.19 | |
| Density | 1.9g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C8H11N3O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of 1,2, 4-Triazine-3,5 (2H,4H)-dione, 2-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-6-Aza-2'-deoxyuridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 2-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazine-3,5-dione |
|---|---|
| Synonym | More Synonyms |
| Description | 6-Aza-2'-deoxyuridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.9g/cm3 |
|---|---|
| Molecular Formula | C8H11N3O5 |
| Molecular Weight | 229.19 |
| Exact Mass | 229.07000 |
| PSA | 117.44000 |
| Index of Refraction | 1.753 |
| 6'-aza-2'deoxyuridine |
| 6-Azauridine deoxyribonucleoside |
| 2'-Deoxy-6-azauridine |